The analysis of gene expression array data of 102 neuroblastomas (Stage 4 and non-MYCN amplified) showed that there is a trend toward the association between high BAP1 and Bax expression and better relapse-free survival of the patients (Fig. 6a, b). This evidence concerns the gene MYCN and neuroblastoma.